Lazard Research & Insights
April 20, 2026
Lazard Healthcare Services Leaders Study 2026
Healthcare leaders are entering 2026 with cautious optimism and a sharper focus on execution — even as the imperative to deploy capital remains intense.
Annual Review of Shareholder Activism 2025
Lazard’s 2025 Review of Shareholder Activism highlights key trends and data in shareholder activism activity throughout the year.
Lazard 2025 M&A Review and 2026 Outlook
Today, Lazard published its 2025 M&A Review and 2026 Outlook Report examining the historical quantitative and qualitative drivers of M&A, the additional factors that accelerated activity in 2025, and the emerging themes that could shape dealmaking in the year ahead.
